10-Q Filing

UNITEDHEALTH GROUP INC CIK: 731766 Q3 2020

Filing Information

Form Type	10-Q
Accession Number	`0000731766-20-000049`
Period End Date	20200930
Filing Date	20201102
Fiscal Year	2020
Fiscal Period	Q3
XBRL Instance	unh-20200930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 90 Income Statement 92 Cash Flow Statement 73 Stockholders Equity 63 Comprehensive Income 48

Balance Sheet 90 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$17.55B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.36B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.87B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.98B	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments	`ShortTermInvestments`	$3.26B	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$3.26B	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$11.82B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$12.17B	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	3.00B	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	3.00B	shares	Point-in-time
Other current receivables, net	`OtherReceivablesNetCurrent`	$9.64B	USD	Point-in-time
Other current receivables, net	`OtherReceivablesNetCurrent`	$13.23B	USD	Point-in-time
Assets under management	`AarpAssetsUnderManagement`	$3.79B	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	949.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	948.00M	shares	Point-in-time
Assets under management	`AarpAssetsUnderManagement`	$3.08B	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.82B	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	949.00M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	948.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.85B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$54.82B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$42.63B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$37.21B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$39.18B	USD	Point-in-time
Property, equipment and capitalized software, net	`PropertyPlantAndEquipmentNet`	$8.70B	USD	Point-in-time
Property, equipment and capitalized software, net	`PropertyPlantAndEquipmentNet`	$8.15B	USD	Point-in-time
Goodwill	`Goodwill`	$65.66B	USD	Point-in-time
Goodwill	`Goodwill`	$68.09B	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$10.37B	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$10.35B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$10.35B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$9.33B	USD	Point-in-time
Total assets	`Assets`	$173.89B	USD	Point-in-time
Total assets	`Assets`	$190.97B	USD	Point-in-time
Medical costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$21.69B	USD	Point-in-time
Medical costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$19.89B	USD	Point-in-time
Medical costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$21.17B	USD	Point-in-time
Medical costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$20.94B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$19.00B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$21.17B	USD	Point-in-time
Short-term borrowings and current maturities of long-term debt	`DebtCurrent`	$3.90B	USD	Point-in-time
Short-term borrowings and current maturities of long-term debt	`DebtCurrent`	$3.87B	USD	Point-in-time
Unearned revenues	`DeferredRevenueCurrent`	$2.39B	USD	Point-in-time
Unearned revenues	`DeferredRevenueCurrent`	$2.62B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$14.60B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$17.97B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$66.60B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$61.78B	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtNoncurrent`	$36.81B	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtNoncurrent`	$39.90B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$2.99B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$3.34B	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$11.19B	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$10.14B	USD	Point-in-time
Total liabilities	`Liabilities`	$121.02B	USD	Point-in-time
Total liabilities	`Liabilities`	$111.73B	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$1.73B	USD	Point-in-time
Redeemable noncontrolling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$1.85B	USD	Point-in-time
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value - 3,000 shares authorized; 949 and 948 issued and outstanding	`CommonStockValue`	$10.00M	USD	Point-in-time
Common stock, $0.01 par value - 3,000 shares authorized; 949 and 948 issued and outstanding	`CommonStockValue`	$9.00M	USD	Point-in-time
Additional Paid in Capital	`AdditionalPaidInCapital`	$7.00M	USD	Point-in-time
Additional Paid in Capital	`AdditionalPaidInCapital`	-	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$69.72B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$61.18B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.58B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-4.49B	USD	Point-in-time
Nonredeemable noncontrolling interests	`MinorityInterest`	$2.87B	USD	Point-in-time
Nonredeemable noncontrolling interests	`MinorityInterest`	$2.82B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.44B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.10B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$55.85B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$66.52B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$54.32B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$57.76B	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests and equity	`LiabilitiesAndStockholdersEquity`	$173.89B	USD	Point-in-time
Total liabilities, redeemable noncontrolling interests and equity	`LiabilitiesAndStockholdersEquity`	$190.97B	USD	Point-in-time

Income Statement 92 line items

Line Item	Tag	Value	Unit	Period
Premiums	`PremiumsEarnedNet`	$50.86B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$142.07B	USD	3 Qtrs
Premiums	`PremiumsEarnedNet`	$150.90B	USD	3 Qtrs
Premiums	`PremiumsEarnedNet`	$47.40B	USD	1 Quarter
Products	`SalesRevenueProductsNet`	$7.55B	USD	1 Quarter
Products	`SalesRevenueProductsNet`	$25.45B	USD	3 Qtrs
Products	`SalesRevenueProductsNet`	$8.78B	USD	1 Quarter
Products	`SalesRevenueProductsNet`	$23.97B	USD	3 Qtrs
Services	`SalesRevenuesServicesNet`	$14.27B	USD	3 Qtrs
Services	`SalesRevenuesServicesNet`	$4.94B	USD	1 Quarter
Services	`SalesRevenuesServicesNet`	$13.76B	USD	3 Qtrs
Services	`SalesRevenuesServicesNet`	$5.12B	USD	1 Quarter
Investment and other income	`InvestmentIncomeInterestAndDividend`	$351.00M	USD	1 Quarter
Investment and other income	`InvestmentIncomeInterestAndDividend`	$1.45B	USD	3 Qtrs
Investment and other income	`InvestmentIncomeInterestAndDividend`	$466.00M	USD	1 Quarter
Investment and other income	`InvestmentIncomeInterestAndDividend`	$1.06B	USD	3 Qtrs
Total revenues	`Revenues`	$191.67B	USD	3 Qtrs
Total revenues	`Revenues`	$181.25B	USD	3 Qtrs
Total revenues	`Revenues`	$60.35B	USD	1 Quarter
Total revenues	`Revenues`	$65.11B	USD	1 Quarter
Medical costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$117.31B	USD	3 Qtrs
Medical costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$117.16B	USD	3 Qtrs
Medical costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$39.04B	USD	1 Quarter
Medical costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$41.64B	USD	1 Quarter
Operating costs	`SellingGeneralAndAdministrativeExpense`	$8.96B	USD	1 Quarter
Operating costs	`SellingGeneralAndAdministrativeExpense`	$30.19B	USD	3 Qtrs
Operating costs	`SellingGeneralAndAdministrativeExpense`	$25.89B	USD	3 Qtrs
Operating costs	`SellingGeneralAndAdministrativeExpense`	$10.17B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$7.93B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$23.12B	USD	3 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$6.63B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$21.61B	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$2.00B	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$709.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$719.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$2.16B	USD	3 Qtrs
Total operating costs	`CostsAndExpenses`	$172.79B	USD	3 Qtrs
Total operating costs	`CostsAndExpenses`	$55.34B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$166.66B	USD	3 Qtrs
Total operating costs	`CostsAndExpenses`	$60.46B	USD	1 Quarter
Earnings from operations	`OperatingIncomeLoss`	$5.01B	USD	1 Quarter
Earnings from operations	`OperatingIncomeLoss`	$18.89B	USD	3 Qtrs
Earnings from operations	`OperatingIncomeLoss`	$14.59B	USD	3 Qtrs
Earnings from operations	`OperatingIncomeLoss`	$4.65B	USD	1 Quarter
Interest expense	`InterestExpense`	$395.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$1.26B	USD	3 Qtrs
Interest expense	`InterestExpense`	$1.27B	USD	3 Qtrs
Interest expense	`InterestExpense`	$449.00M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$4.26B	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$17.63B	USD	3 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$4.57B	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$13.32B	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$936.00M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$1.00B	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$2.75B	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$4.21B	USD	3 Qtrs
Net earnings	`ProfitLoss`	$10.57B	USD	3 Qtrs
Net earnings	`ProfitLoss`	$3.63B	USD	1 Quarter
Net earnings	`ProfitLoss`	$3.26B	USD	1 Quarter
Net earnings	`ProfitLoss`	$13.42B	USD	3 Qtrs
Earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$91.00M	USD	1 Quarter
Earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$273.00M	USD	3 Qtrs
Earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$84.00M	USD	1 Quarter
Earnings attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$226.00M	USD	3 Qtrs
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$13.19B	USD	3 Qtrs
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$3.54B	USD	1 Quarter
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$10.30B	USD	3 Qtrs
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$3.17B	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$10.82	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$13.90	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$3.34	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$3.73	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$3.67	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$13.73	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$10.65	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$3.30	USD	1 Quarter
Basic weighted-average number of common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	949.00M	shares	1 Quarter
Basic weighted-average number of common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	952.00M	shares	3 Qtrs
Basic weighted-average number of common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	949.00M	shares	3 Qtrs
Basic weighted-average number of common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	950.00M	shares	1 Quarter
Dilutive effect of common share equivalents	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	12.00M	shares	1 Quarter
Dilutive effect of common share equivalents	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	14.00M	shares	1 Quarter
Dilutive effect of common share equivalents	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	15.00M	shares	3 Qtrs
Dilutive effect of common share equivalents	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	12.00M	shares	3 Qtrs
Diluted weighted-average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	962.00M	shares	1 Quarter
Diluted weighted-average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	967.00M	shares	3 Qtrs
Diluted weighted-average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	961.00M	shares	3 Qtrs
Diluted weighted-average number of common shares outstanding	`WeightedAverageNumberOfDilutedSharesOutstanding`	963.00M	shares	1 Quarter
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	9.00M	shares	3 Qtrs
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	6.00M	shares	1 Quarter
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	10.00M	shares	3 Qtrs
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents	`AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount`	12.00M	shares	1 Quarter

Cash Flow Statement 73 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$10.57B	USD	3 Qtrs
Net earnings	`ProfitLoss`	$3.63B	USD	1 Quarter
Net earnings	`ProfitLoss`	$3.26B	USD	1 Quarter
Net earnings	`ProfitLoss`	$13.42B	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$2.00B	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$709.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$719.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$2.16B	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$119.00M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$177.00M	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$527.00M	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$525.00M	USD	3 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$-48.00M	USD	3 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$181.00M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-957.00M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$194.00M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$2.70B	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$2.18B	USD	3 Qtrs
Medical costs payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$-615.00M	USD	3 Qtrs
Medical costs payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$223.00M	USD	3 Qtrs
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$3.44B	USD	3 Qtrs
Accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$105.00M	USD	3 Qtrs
Unearned revenues	`IncreaseDecreaseInDeferredRevenue`	$60.00M	USD	3 Qtrs
Unearned revenues	`IncreaseDecreaseInDeferredRevenue`	$-132.00M	USD	3 Qtrs
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$16.07B	USD	3 Qtrs
Cash flows from operating activities	`NetCashProvidedByUsedInOperatingActivities`	$12.26B	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$13.39B	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$11.57B	USD	3 Qtrs
Sales of investments	`ProceedsFromSaleOfAvailableForSaleSecurities`	$6.20B	USD	3 Qtrs
Sales of investments	`ProceedsFromSaleOfAvailableForSaleSecurities`	$4.89B	USD	3 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$5.16B	USD	3 Qtrs
Maturities of investments	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$5.30B	USD	3 Qtrs
Cash paid for acquisitions, net of cash assumed	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$8.20B	USD	3 Qtrs
Cash paid for acquisitions, net of cash assumed	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$4.33B	USD	3 Qtrs
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.42B	USD	3 Qtrs
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.48B	USD	3 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-338.00M	USD	3 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$165.00M	USD	3 Qtrs
Cash flows used for investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-11.31B	USD	3 Qtrs
Cash flows used for investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-7.35B	USD	3 Qtrs
Common share repurchases	`PaymentsForRepurchaseOfCommonStock`	$2.54B	USD	3 Qtrs
Common share repurchases	`PaymentsForRepurchaseOfCommonStock`	$5.10B	USD	3 Qtrs
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$1.02B	USD	Point-in-time
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$1.19B	USD	Point-in-time
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$1.19B	USD	Point-in-time
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$2.91B	USD	3 Qtrs
Cash dividends paid	`PaymentsOfDividendsCommonStock`	$3.40B	USD	3 Qtrs
Proceeds from common stock issuances	`ProceedsFromIssuanceOfCommonStock`	$740.00M	USD	3 Qtrs
Proceeds from common stock issuances	`ProceedsFromIssuanceOfCommonStock`	$1.21B	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.50B	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.25B	USD	3 Qtrs
(Repayments of) proceeds from short-term borrowings, net	`ProceedsFromRepaymentsOfCommercialPaper`	$4.00B	USD	3 Qtrs
(Repayments of) proceeds from short-term borrowings, net	`ProceedsFromRepaymentsOfCommercialPaper`	$-423.00M	USD	3 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$5.44B	USD	3 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$4.86B	USD	3 Qtrs
Customer funds administered	`IncreaseDecreaseInCustomerDeposits`	$420.00M	USD	3 Qtrs
Customer funds administered	`IncreaseDecreaseInCustomerDeposits`	$249.00M	USD	3 Qtrs
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-449.00M	USD	3 Qtrs
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-756.00M	USD	3 Qtrs
Cash flows (used for) from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$587.00M	USD	3 Qtrs
Cash flows (used for) from financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.99B	USD	3 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-160.00M	USD	3 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-37.00M	USD	3 Qtrs
Increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$6.57B	USD	3 Qtrs
Increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.50B	USD	3 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$17.55B	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$12.36B	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$10.87B	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$10.98B	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$17.55B	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$12.36B	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$10.87B	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$10.98B	USD	Point-in-time

Stockholders Equity 63 line items

Line Item	Tag	Value	Unit	Period
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$3.58	USD	3 Qtrs
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$1.08	USD	Point-in-time
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$1.08	USD	1 Quarter
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$3.06	USD	3 Qtrs
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$1.25	USD	Point-in-time
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$1.25	USD	1 Quarter
Common Stock, Dividends, Per Share, Cash Paid	`CommonStockDividendsPerShareCashPaid`	$1.25	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.44B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.10B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$55.85B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$66.52B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$54.32B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$57.76B	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	949.00M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	948.00M	shares	Point-in-time
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$13.19B	USD	3 Qtrs
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$3.54B	USD	1 Quarter
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$10.30B	USD	3 Qtrs
Net earnings attributable to UnitedHealth Group common shareholders	`NetIncomeLoss`	$3.17B	USD	1 Quarter
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$10.49B	USD	3 Qtrs
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$3.23B	USD	1 Quarter
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$13.35B	USD	3 Qtrs
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$3.62B	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-436.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-916.00M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$451.00M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$56.00M	USD	1 Quarter
Issuances of common stock, and related tax effects	`StockIssuedDuringPeriodValueNewIssues`	$321.00M	USD	1 Quarter
Issuances of common stock, and related tax effects	`StockIssuedDuringPeriodValueNewIssues`	$277.00M	USD	1 Quarter
Issuances of common stock, and related tax effects	`StockIssuedDuringPeriodValueNewIssues`	$929.00M	USD	3 Qtrs
Issuances of common stock, and related tax effects	`StockIssuedDuringPeriodValueNewIssues`	$438.00M	USD	3 Qtrs
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$130.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$131.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$509.00M	USD	3 Qtrs
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$521.00M	USD	3 Qtrs
Common share repurchases	`StockRepurchasedAndRetiredDuringPeriodValue`	$850.00M	USD	1 Quarter
Common share repurchases	`StockRepurchasedAndRetiredDuringPeriodValue`	$5.10B	USD	3 Qtrs
Common share repurchases	`StockRepurchasedAndRetiredDuringPeriodValue`	$600.00M	USD	1 Quarter
Common share repurchases	`StockRepurchasedAndRetiredDuringPeriodValue`	$2.54B	USD	3 Qtrs
Cash dividends paid on common shares	`DividendsCash`	$1.02B	USD	1 Quarter
Cash dividends paid on common shares	`DividendsCash`	$3.40B	USD	3 Qtrs
Cash dividends paid on common shares	`DividendsCash`	$1.19B	USD	1 Quarter
Cash dividends paid on common shares	`DividendsCash`	$2.91B	USD	3 Qtrs
Redeemable noncontrolling interests fair value and other adjustments	`MinorityInterestChangeInRedemptionValue`	$8.00M	USD	1 Quarter
Redeemable noncontrolling interests fair value and other adjustments	`MinorityInterestChangeInRedemptionValue`	$-35.00M	USD	1 Quarter
Redeemable noncontrolling interests fair value and other adjustments	`MinorityInterestChangeInRedemptionValue`	$-129.00M	USD	3 Qtrs
Redeemable noncontrolling interests fair value and other adjustments	`MinorityInterestChangeInRedemptionValue`	$-277.00M	USD	3 Qtrs
Acquisition and other adjustments of nonredeemable noncontrolling interests	`MinorityInterestPeriodIncreaseDecrease`	$-8.00M	USD	1 Quarter
Acquisition and other adjustments of nonredeemable noncontrolling interests	`MinorityInterestPeriodIncreaseDecrease`	$48.00M	USD	3 Qtrs
Acquisition and other adjustments of nonredeemable noncontrolling interests	`MinorityInterestPeriodIncreaseDecrease`	$42.00M	USD	3 Qtrs
Acquisition and other adjustments of nonredeemable noncontrolling interests	`MinorityInterestPeriodIncreaseDecrease`	$-7.00M	USD	1 Quarter
Distribution to nonredeemable noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$211.00M	USD	3 Qtrs
Distribution to nonredeemable noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$66.00M	USD	1 Quarter
Distribution to nonredeemable noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$148.00M	USD	3 Qtrs
Distribution to nonredeemable noncontrolling interests	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$72.00M	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.44B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.10B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$55.85B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$66.52B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$54.32B	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$57.76B	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	949.00M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	948.00M	shares	Point-in-time

Comprehensive Income 48 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`ProfitLoss`	$10.57B	USD	3 Qtrs
Net earnings	`ProfitLoss`	$3.63B	USD	1 Quarter
Net earnings	`ProfitLoss`	$3.26B	USD	1 Quarter
Net earnings	`ProfitLoss`	$13.42B	USD	3 Qtrs
Gross unrealized gains on investment securities during the period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$230.00M	USD	1 Quarter
Gross unrealized gains on investment securities during the period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$919.00M	USD	3 Qtrs
Gross unrealized gains on investment securities during the period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$1.24B	USD	3 Qtrs
Gross unrealized gains on investment securities during the period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$148.00M	USD	1 Quarter
Income tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$53.00M	USD	1 Quarter
Income tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$37.00M	USD	1 Quarter
Income tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$285.00M	USD	3 Qtrs
Income tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$214.00M	USD	3 Qtrs
Total unrealized gains, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$958.00M	USD	3 Qtrs
Total unrealized gains, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$177.00M	USD	1 Quarter
Total unrealized gains, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$111.00M	USD	1 Quarter
Total unrealized gains, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$705.00M	USD	3 Qtrs
Gross reclassification adjustment for net realized gains included in net earnings	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$70.00M	USD	3 Qtrs
Gross reclassification adjustment for net realized gains included in net earnings	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$50.00M	USD	3 Qtrs
Gross reclassification adjustment for net realized gains included in net earnings	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$69.00M	USD	1 Quarter
Gross reclassification adjustment for net realized gains included in net earnings	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$21.00M	USD	1 Quarter
Income tax effect	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	$12.00M	USD	3 Qtrs
Income tax effect	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	$16.00M	USD	3 Qtrs
Income tax effect	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	$16.00M	USD	1 Quarter
Income tax effect	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	$5.00M	USD	1 Quarter
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$53.00M	USD	1 Quarter
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$54.00M	USD	3 Qtrs
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$16.00M	USD	1 Quarter
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$38.00M	USD	3 Qtrs
Total foreign currency translation losses	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-1.58B	USD	3 Qtrs
Total foreign currency translation losses	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-453.00M	USD	3 Qtrs
Total foreign currency translation losses	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-560.00M	USD	1 Quarter
Total foreign currency translation losses	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-39.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-436.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-916.00M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$451.00M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$56.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$3.19B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$11.02B	USD	3 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$12.50B	USD	3 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$3.31B	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$84.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$226.00M	USD	3 Qtrs
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$273.00M	USD	3 Qtrs
Comprehensive income attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$91.00M	USD	1 Quarter
Comprehensive income attributable to UnitedHealth Group common shareholders	`ComprehensiveIncomeNetOfTax`	$10.75B	USD	3 Qtrs
Comprehensive income attributable to UnitedHealth Group common shareholders	`ComprehensiveIncomeNetOfTax`	$3.10B	USD	1 Quarter
Comprehensive income attributable to UnitedHealth Group common shareholders	`ComprehensiveIncomeNetOfTax`	$3.23B	USD	1 Quarter
Comprehensive income attributable to UnitedHealth Group common shareholders	`ComprehensiveIncomeNetOfTax`	$12.28B	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.